Mitesh

MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) Drug alert number: EL(26)A/05 Date issued: 2 February 2026 Accord Healthcare limited is recalling a single batch due to an out of specification test result. DMRC reference number: DMRC-38091819 Company name: Accord Healthcare Ltd Medicine Details Carmustine [...]

The post MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 11 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 February 2026. This takes the total [...]

The post 11 products added to the Discount Not Deducted (DND) list from February 2026 appeared first on Community Pharmacy England.

NHS Business Services Authority (NHSBSA) has announced that, from 1 February 2026 all end‑of‑month paper prescription bundles/batch submissions must be sent to their office at Greenfinch Way – see address below: Unit 5, Greenfinch Way Newburn Riverside Newcastle upon Tyne NE15 8NX Pharmacy teams should despatch their January 2026 prescription bundles (to be submitted by 5th [...]

The post New address to submit end of month paper prescription bundles appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed the Serious Shortage Protocol (SSP086) for Latanoprost 50 micrograms/ml / Timolol 5 mg/ml (Fixapost®) eye drops 0.2 ml unit dose preservative‑free will expire at 23:59pm Friday 23rd January 2026  SSP086 was originally set to expire on 6th February 2026 but its expiry date has been brought forward because [...]

The post Expiry of SSP086 Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug Alert Number: EL(26)A/02 Date issued: 21 January 2026 Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule [...]

The post MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.